Article Figures & Data
Figures
- Figure 1.
NACE, MACCE, and Any Bleeding at 30 Days
Biv, bivalirudin; H + T, heparin plus tirofiban; MACCE, major adverse cardiac and cerebrovascular events; NACE, adverse clinical events; UFH, unfractionated heparin.
Reproduced with permission from Y Han, MD.
- Figure 2.
NACE at 1 Year
Biv, bivalirudin; H + T, heparin plus tirofiban; NACE, adverse clinical events; UFH, unfractionated heparin.
Reproduced with permission from Y Han, MD.
- Figure 3.
Treatment-Related Bleeding
Biv, bivalirudin; H + T, heparin plus tirofiban; UFH, unfractionated heparin.
Reproduced with permission from Y Han, MD.
Tools
Bivalirudin More Beneficial than Heparin in Patients with AMI Undergoing PCI: The BRIGHT Trial
Permalink:
Table of contents
Cited By...
- No citing articles found.